AI and new strategies are helping combat rising antibiotic resistance by analyzing genetic data to track superbugs and develop novel treatments.
Canada's therapy innovations face patient access hurdles, as a gap between scientific breakthroughs and healthcare coverage persists.
Large language models are being tested to capture chronic pain details missed by standard medical scores, according to a study published October…
FDA approves new hepatitis B treatment bepirovirsen (Hibsago) by GSK for adults with chronic HBV infection.
The FDA has expanded the approval of tildrakizumab for adults with active psoriatic arthritis, adding to its use for moderate-to-severe plaque psoriasis.
AI models give wrong medication doses in about 2% of cases, Doximity research finds, raising concerns about AI in healthcare.
UHS cuts 2026 earnings forecast amid surgery decline, outpatient shift.
Proposed U.S. Census changes may seriously threaten public health by impacting health research and federal programs.
Subcutaneous efgartigimod significantly improves ocular myasthenia symptoms, with III ADAPT OCULUS data showing less double vision and drooping eyelids.
Meibomian gland dysfunction treatment may be improved with new device Meiboleyes, designed to address drawbacks of existing tools.